These studies have significant implications for our basic understanding of LTA4H biology, the cross-talk between protease–matrikine networks, the role of PGP in the pathology and development of chronic lung diseases and the design and application of LTA4H inhibitors by pharmaceutical companies. Here, LTA4H is linked to chronic lung disease.